Nothem Meghan E, Salazar Alan G, Nanchal Rahul S, Bergl Paul A
Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Department of Internal Medicine, Division of Infectious Diseases, Rush University Medical Center, Chicago, IL.
Crit Care Explor. 2023 Jun 23;5(7):e0936. doi: 10.1097/CCE.0000000000000936. eCollection 2023 Jul.
Critically ill patients frequently experience acute encephalopathy, often colloquially termed "altered mental status" (AMS); however, there are no consensus guidelines or criteria about performing lumbar puncture (LP) and advanced neuroimaging in medical ICU patients with unexplained encephalopathy.
We sought to characterize the yield of combined LP and brain MRI (bMRI) in such patients as determined by both the frequency of abnormal results and the therapeutic efficacy of these investigations, that is, how often results changed management.
Retrospective cohort study of medical ICU patients admitted to a tertiary academic center between 2012 and 2018 who had documented diagnoses of "AMS" and/or synonymous terms, no clear etiology of encephalopathy, and had undergone both LP and bMRI.
The primary outcome was the frequency of abnormal diagnostic testing results determined objectively for LP using cerebrospinal fluid (CSF) findings and subjectively for bMRI through team agreement on imaging findings deemed significant through retrospective chart review. We subjectively determined the frequency of therapeutic efficacy. Finally, we analyzed the effect of other clinical variables on the likelihood of discovering abnormal CSF and bMRI findings through chi-square tests and multivariate logistic regression.
One hundred four patients met inclusion criteria. Fifty patients (48.1%) had an abnormal CSF profile or definitive microbiological or cytological data by LP, 44 patients (42.3%) had bMRI with significant abnormal findings, and 74 patients (71.2%) had abnormal results on at least one of these investigations. Few clinical variables were associated with the abnormal findings in either investigation. We judged 24.0% (25/104) of bMRI and 26.0% (27/104) of LPs to have therapeutic efficacy with moderate interobserver reliability.
Determining when to perform combined LP and bMRI in ICU patients with unexplained acute encephalopathy must rely on clinical judgment. These investigations have a reasonable yield in this selected population.
重症患者常出现急性脑病,通俗地说常称为“精神状态改变”(AMS);然而,对于医学重症监护病房(ICU)中患有不明原因脑病的患者进行腰椎穿刺(LP)和高级神经影像学检查,尚无共识性指南或标准。
我们试图通过异常结果的频率和这些检查的治疗效果,即结果改变治疗方案的频率,来描述此类患者联合进行LP和脑部磁共振成像(bMRI)的检查结果。
设计、地点和参与者:对2012年至2018年期间入住三级学术中心的医学ICU患者进行回顾性队列研究,这些患者有“AMS”和/或同义术语的记录诊断,脑病病因不明,且接受了LP和bMRI检查。
主要结局是根据脑脊液(CSF)检查结果客观确定的LP异常诊断检查结果的频率,以及通过回顾性病历审查由团队对被认为具有重要意义的影像学检查结果达成一致主观确定的bMRI异常诊断检查结果的频率。我们主观确定治疗效果的频率。最后,我们通过卡方检验和多因素逻辑回归分析了其他临床变量对发现异常CSF和bMRI检查结果可能性的影响。
104例患者符合纳入标准。50例患者(48.1%)通过LP有异常的CSF检查结果或明确的微生物学或细胞学数据,44例患者(42.3%)bMRI有明显异常结果,74例患者(71.2%)至少一项检查结果异常。很少有临床变量与这两项检查中的异常结果相关。我们判断24.0%(25/104)的bMRI和26.0%(27/104)的LP具有治疗效果,观察者间可靠性中等。
确定何时对患有不明原因急性脑病的ICU患者联合进行LP和bMRI检查必须依靠临床判断。这些检查在这一特定人群中有合理的检查结果。